Is Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences's patent grant rate increasing or decreasing?

Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences's recent grant velocity is -29% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences

Q: Where does Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences ranks #11,798 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 26 granted patents across 29 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Shanghai ranks #11,798 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 29 technology areas.

#11,798
of 49,997 US assignees by volume: Top 34%
by Innovation Score (40.9/100): 15.0
avg claims per patent: -29%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11798 · Foreign Corporation #11,798 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,798/49,997
PHOTO-FINISH Rebound Therapeutics
CPC-FOCUS C07D · 29 areas
INNOV-PAR 40.9/100
CLAIMS-RICH 15.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -29% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rebound Therapeutics Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Shanghai’s 40.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (28%) Velocity 1.5 pts (4%) Breadth 19.0 pts (46%) Claim depth 9.0 pts (22%)

Qualcomm Incorporated · highest

85
Glashütter Uhrenbetr… · near

41
Medtronic Holding Sarl · near

41
Quip NYC · near

41
Shanghai Institute… · this assignee

41
Walker Digital… · near

41
3D Lighting… · lowest

7

What this shows Shanghai's Innovation Score is 40.9/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Shanghai?

Each dot is one of Shanghai’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shanghai’s own 15.0 claims/patent is ABOVE the 11.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Shanghai vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Shanghai's grants concentrate

Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences is a focused PatentsView assignee: 29 CPC subclasses with 57.7% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2019. By volume, Shanghai sits between Rebound Therapeutics Corporation and SII Crystal Technology Inc..

Shanghai's three-year grant acceleration

Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences shows 2 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Rebound Therapeut…

26
Regal Beloit Aust…

26
Research Products

26
Semicon Light

26
Sheen World Techn…

26
Shenzhen Sunway C…

26
Shire-nps Pharmac…

26
SII Crystal Techn…

26
Shanghai Institut… ◀

26

What this shows Shanghai holds 26 patents at rank #11,793, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Shanghai

By rank, the assignees closest to #11,793 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Shanghai's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Shanghai, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Shanghai ranks #570 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Quip NYC Inc. 41 Glashütter Uhrenbetrieb GmbH 41 Walker Digital Table Systems, LLC 41 Medtronic Holding Company Sarl 41

Shanghai's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	11.5%
2016	5	19.2%
2017	2	7.7%
2018	3	11.5%
2019	1	3.8%
2020	3	11.5%
2021	5	19.2%
2022	1	3.8%
2024	1	3.8%
2025partial year	2	7.7%

Which technologies does Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences patent most?

C07D - Heterocyclic Compounds 15

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

C07C - Acyclic OR Carbocyclic Compounds 12

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 8

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 6

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

B01D - Separation 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

C22B - Production AND Refining OF Metals ; Pretreatment OF RAW Materials 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

C07J - Steroids 1

C10M - Lubricating Compositions ; USE OF Chemical Substances Either Alone OR AS Lubricating Ingredients IN A Lubricating Composition 1

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 1

Top 15 of 29 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences's patent record in context - here's where to go next.

Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences's lead technology class is C07D (Heterocyclic Compounds), 57.7% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #11,798 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Shanghai Institute OF Organic Chemistry, Chinese Academy OF Sciences against Rebound Therapeutics Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.